What this trial studies
Preoperative serum uric acid significantly impacted acute kidney injury in female patients undergoing non-cardiac surgery, with differential effects observed before and after menopause.
Conditions in scope
- Uric Acid
Interventions
- No Intervention: Observational Cohort (Other) — This observational cohort includes female patients undergoing non-cardiac surgery. No intervention was administered as part of the study protocol. Preoperative serum uric acid levels were measured, and patients were followed for the development of postoperative acute kidney injury. Data were…
Who can join
Women only · Ages 18 Years and up
Inclusion criteria
- Female patients aged 18 years and older who underwent elective non-cardiac surgery
Exclusion criteria
- Patients with gout
- Patients who underwent nephrectomy or kidney transplantation (either as recipients or donors)
- Patients diagnosed with chronic kidney disease or who had already undergone kidney replacement therapy
- Patients with estimated glomerular filtration rate \< 30 mL/min/1.73m²; and patients with incomplete data or missing laboratory values
Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.
Where it’s happening
| City | State / Region | Facility | Site status |
|---|---|---|---|
| Seoul | Songpa | Asan Medical Center | Unknown |
Status & timeline
- Overall status: Completed
- Study type: Observational
- Phase: N/A
- Start date: 2024-07-30
- Primary completion: 2024-12-20
- Last update posted: 2025-07-02
- First posted: 2025-07-01
Sponsor & contact
Lead sponsor: Asan Medical Center (Other)
For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.
Outcome measures
Primary outcomes
- Incidence of Postoperative Acute Kidney Injury (7 days post-surgery)
Related ClearedRx care
If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.
Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT07044934 before contacting a site.
ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.